Trials / Completed
CompletedNCT00538304
A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 222 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A one month study which will determine the safety and efficacy of bimatoprost eye drops in patients with glaucoma or ocular hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bimatoprost eye drops | 1 drop in each eye daily for 1 month |
| DRUG | placebo | 1 drop in each eye daily for 1 month |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2007-10-02
- Last updated
- 2019-04-23
- Results posted
- 2011-10-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00538304. Inclusion in this directory is not an endorsement.